These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 27267972)
1. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update. Ghosh N; Dutta M; Singh B; Banerjee R; Bhattacharyya P; Chaudhury K Expert Rev Mol Diagn; 2016 Aug; 16(8):897-913. PubMed ID: 27267972 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Biomarkers Based on Proteomic Technology in COPD: A Recent Review. Fang H; Liu Y; Yang Q; Han S; Zhang H Int J Chron Obstruct Pulmon Dis; 2023; 18():1353-1365. PubMed ID: 37408604 [TBL] [Abstract][Full Text] [Related]
3. Multi-omics study on biomarker and pathway discovery of chronic obstructive pulmonary disease. Tang Y; Chen Z; Fang Z; Zhao J; Zhou Y; Tang C J Breath Res; 2021 Sep; 15(4):. PubMed ID: 34280912 [TBL] [Abstract][Full Text] [Related]
4. Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation. Sin DD; Hollander Z; DeMarco ML; McManus BM; Ng RT Am J Respir Crit Care Med; 2015 Nov; 192(10):1162-70. PubMed ID: 26176936 [TBL] [Abstract][Full Text] [Related]
5. Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives. Li CL; Liu SF Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000454 [TBL] [Abstract][Full Text] [Related]
6. A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease. Prokić I; Lahousse L; de Vries M; Liu J; Kalaoja M; Vonk JM; van der Plaat DA; van Diemen CC; van der Spek A; Zhernakova A; Fu J; Ghanbari M; Ala-Korpela M; Kettunen J; Havulinna AS; Perola M; Salomaa V; Lind L; Ärnlöv J; Stricker BHC; Brusselle GG; Boezen HM; van Duijn CM; Amin N BMC Pulm Med; 2020 Jul; 20(1):193. PubMed ID: 32677943 [TBL] [Abstract][Full Text] [Related]
7. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine. Pecak M; Korošec P; Kunej T OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718 [TBL] [Abstract][Full Text] [Related]
15. Proteomics-based biomarkers in chronic obstructive pulmonary disease. Chen H; Wang D; Bai C; Wang X J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909 [TBL] [Abstract][Full Text] [Related]
16. Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease. Zhao P; Li J; Yang L; Li Y; Tian Y; Li S Mol Med Rep; 2018 Apr; 17(4):5247-5257. PubMed ID: 29393428 [TBL] [Abstract][Full Text] [Related]
18. Proteomics and metabolomics profiling reveal panels of circulating diagnostic biomarkers and molecular subtypes in stable COPD. Zhang Z; Wang J; Li Y; Liu F; Chen L; He S; Lin F; Wei X; Fang Y; Li Q; Zhou J; Lu W Respir Res; 2023 Mar; 24(1):73. PubMed ID: 36899372 [TBL] [Abstract][Full Text] [Related]
19. [Omics biomarkers and early diagnostics]. Moshkovskii SA Biomed Khim; 2017 Oct; 63(5):369-372. PubMed ID: 29080866 [TBL] [Abstract][Full Text] [Related]
20. Integrating Transcriptomics, Proteomics, and Metabolomics Profiling with System Pharmacology for the Delineation of Long-Term Therapeutic Mechanisms of Bufei Jianpi Formula in Treating COPD. Zhao P; Li J; Li Y; Tian Y; Yang L; Li S Biomed Res Int; 2017; 2017():7091087. PubMed ID: 28424787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]